Co-Diagnostics (CODX) said Wednesday it closed a previously announced registered direct offering of 12.7 million common shares that were priced at $0.55 each.
The molecular diagnostics company said it plans to use the funds for working capital and general corporate purposes.
Shares of Co-Diagnostics were down over 12% in recent trading on Wednesday.
Price: 0.50, Change: -0.07, Percent Change: -12.11
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.